← Back to Clinical Trials
Recruiting NCT06573476

NCT06573476 Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06573476
Status Recruiting
Phase —
Sponsor Friends Research Institute, Inc.
Condition Opioid Use Disorder
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2025-06-25
Primary Completion 2027-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
PRC supported text + AI driven CSDH-enhanced textAI driven CSDH-enhanced text onlyTreatment as Usual (TAU)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2025-06-25 with a primary completion date of 2027-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to adapt an existing Cultural Structural Humility (CSH) training into a video format for peer recovery coaches (PRCs) and refine an AI-driven texting tool to reinforce the training. After refining these tools using user-centered design, a pilot test will be conducted to assess their impact on the uptake of opioid treatment and social services. The study will also evaluate the feasibility and effectiveness of the intervention to inform future large-scale trials.

Eligibility Criteria

Inclusion Criteria: * ≥18 years of age * fluent in English * self-reported non-prescription opioid use \<30 days prior to consent * provision of informed consent * planned stay in NYC ≥3 months * Black and/or Latinx race/ethnicity * positive urine toxicology for opioids per EMR records or study staff administered random saliva drug testing * diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) * self-reported interest in initiating buprenorphine in primary care, or elsewhere. Exclusion Criteria: * inability to comprehend text content written at a 3rd grade reading level * physical or visual disability preventing mobile phone use

Contact & Investigator

Central Contact

Ana Ventuneac, PHd

✉ aventuneac@startny.org

📞 718-260-2931

Principal Investigator

Ana Ventuneac

STUDY DIRECTOR

START Treatment and Recovery

Frequently Asked Questions

Who can join the NCT06573476 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Opioid Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06573476 currently recruiting?

Yes, NCT06573476 is actively recruiting participants. Contact the research team at aventuneac@startny.org for enrollment information.

Where is the NCT06573476 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT06573476 clinical trial?

NCT06573476 is sponsored by Friends Research Institute, Inc.. The principal investigator is Ana Ventuneac at START Treatment and Recovery. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology